Repare Therapeutics to Participate in Two Upcoming Investor Conferences

Rhea-AI Summary

Repare Therapeutics Inc. announces participation in upcoming investor conferences to discuss precision oncology. Details include presentations at TD Cowen 44th Annual Healthcare Conference and Bloom Burton 2024 Healthcare Investor Conference.

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)-- Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate at two upcoming investor conferences. Details for the presentations are as follows.

TD Cowen 44^th Annual Healthcare Conference
Panel Discussion: Gynecological Cancers
Date: Tuesday, March 5, 2024
Time: 10:30 a.m. Eastern Time
Location: Boston, MA

Bloom Burton 2024 Healthcare Investor Conference
Company Overview
Date: Tuesday, April 16, 2024
Time: 3:30 p.m. Eastern Time
Location: Toronto, ON

A live webcast of the TD Cowen corporate panel discussion and Bloom Burton company overview can be accessed in the Investor section of the Company’s website at https://ir.reparerx.com/news-and-events/events. A replay of the webcast will be archived on the Company’s website for at least 30 days.

About Repare Therapeutics, Inc.
Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes lunresertib (also known as RP-6306), a PKMYT1 inhibitor currently in Phase 1/2 clinical development; camonsertib (also known as RP-3500), a potential leading ATR inhibitor currently in Phase 1/2 clinical development; RP-1664, a Phase 1 PLK4 inhibitor; RP-3467, a preclinical Polθ ATPase inhibitor program; as well as additional, undisclosed preclinical programs. For more information, please visit reparerx.com and follow @Reparerx on X (formerly Twitter) and LinkedIn.

SNIPRx^® is a registered trademark of Repare Therapeutics Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240229323391/en/

Repare Contact:

Robin Garner

Vice President and Head of Investor Relations

Repare Therapeutics Inc.

investor@reparerx.com

Investors:

Matthew DeYoung

Argot Partners

repare@argotpartners.com

Media:

David Rosen

Argot Partners

david.rosen@argotpartners.com

212-600-1902

Source: Repare Therapeutics Inc.

When will Repare Therapeutics participate in the TD Cowen 44th Annual Healthcare Conference?

Repare Therapeutics will participate in the TD Cowen 44th Annual Healthcare Conference on Tuesday, March 5, 2024.

What will be the topic of discussion at the TD Cowen conference for Repare Therapeutics?

The topic of discussion at the TD Cowen conference for Repare Therapeutics will be Gynecological Cancers.

Where will the TD Cowen 44th Annual Healthcare Conference take place for Repare Therapeutics?

The TD Cowen 44th Annual Healthcare Conference for Repare Therapeutics will take place in Boston, MA.

When is the Bloom Burton 2024 Healthcare Investor Conference scheduled for Repare Therapeutics?

The Bloom Burton 2024 Healthcare Investor Conference for Repare Therapeutics is scheduled for Tuesday, April 16, 2024.

What will be discussed at the Bloom Burton 2024 Healthcare Investor Conference for Repare Therapeutics?

The discussion at the Bloom Burton 2024 Healthcare Investor Conference for Repare Therapeutics will be a Company Overview.

Where will the Bloom Burton 2024 Healthcare Investor Conference take place for Repare Therapeutics?

The Bloom Burton 2024 Healthcare Investor Conference for Repare Therapeutics will take place in Toronto, ON.